Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis - Summary - MDSpire

Correction: A Network Meta-Analysis Comparing Glucagon-Like Peptide-1 Receptor Agonists, Metformin, and Inositol on Anthropometric and Metabolic Improvements in Women with Polycystic Ovary Syndrome

  • By

  • Asad Omarion

  • Yaman Ayasa

  • Zainab Omarion

  • Batoul Jayouse

  • Hazem Ayesh

  • July 20, 2026

Share

Objective:

To correct the figure captions in the comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol.

Approach:
  • Correction Details: The captions for Figures 3, 4, and 5 were shifted one position ahead of their corresponding images and have been corrected.
Key Findings:
  • Figure 3 caption corrected to match the network plot showing treatment comparisons.
  • Figure 4 caption corrected to match the forest plot for BMI change.
  • Figure 5 caption corrected to match the forest plot for waist circumference change.
  • Figure 6 caption corrected to match the forest plot for HOMA-IR change.
Interpretation:

The corrections ensure that each figure is accurately described by its corresponding caption.

Conclusion:

The original article has been updated to reflect these corrections.

Sources:

Original Source(s)

Correction: Comparative analysis of glucagon-like peptide-1 receptor agonists, metformin, and inositol in improving anthropometric and metabolic outcomes in women with polycystic ovary syndrome: a network meta-analysis

  • by Asad Omarion, Yaman Ayasa, Zainab Omarion, Batoul Jayouse, Hazem Ayesh

  • July 20, 2026

Related Content

Sexual dysfunction associated with antidepressants and antipsychotics: a structured narrative review of mechanisms, assessment, and personalized management

Interpretable machine learning for presurgical differentiation of Hürthle cell carcinoma and adenoma: a SHAP-augmented approach

Correlations between multiple obesity diagnostic criteria and fracture risk as well as cardiovascular diseases in patients with diabetes mellitus